Evidence map›Paper›PMID 38382894›Full record

SynthesisActa obstetricia et gynecologica Scandinavica2024

Early suppression policies protected pregnant women from COVID-19 in 2020: A population-based surveillance from the Nordic countries.

Reetta Varpula, Outi Äyräs, Anna J M Aabakke, Kari Klungsøyr, Teresia Svanvik, Julia Kanerva, Eva Jonasdottir, Camilla Tjønneland Mentzoni, Lars Thurn, Elin Jones and 12 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Acta obstetricia et gynecologica Scandinavica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Reetta VarpulaDepartment of Obstetrics and Gynecology, Helsinki University Hospital and Helsinki University, Helsinki, Finland.ORCID 0000-0002-4827-4655
Outi ÄyräsDepartment of Obstetrics and Gynecology, Helsinki University Hospital and Helsinki University, Helsinki, Finland.ORCID 0000-0002-2423-611X
Anna J M AabakkeDepartment of Obstetrics and Gynecology, Copenhagen University Hospital-Holbæk, Holbæk, Denmark.ORCID 0000-0003-4754-506X
Kari KlungsøyrDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Teresia SvanvikDepartment of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID 0000-0003-1947-679X
Julia KanervaDepartment of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Eva JonasdottirDepartment of Obstetrics and Gynecology, Landspitali University Hospital, Reykjavik, Iceland.
Camilla Tjønneland MentzoniDepartment for Health Promotion, Norwegian Institute of Public Health, Bergen, Norway.ORCID 0000-0002-1437-2660
Lars ThurnDepartment of Obstetrics and Gynecology, Skåne University Hospital, Lund, Sweden.
Elin JonesDepartment of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden.
Lisa FredrikssonDepartment of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden.
Karin PetterssonDepartment of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden.
Lill Trine NyfløtNorwegian Research Center for Women's Health, Oslo University Hospital, Oslo, Norway.
Siri VangenNorwegian Research Center for Women's Health, Oslo University Hospital, Oslo, Norway.ORCID 0000-0003-4681-4774
Kjerstine RøeDepartment of Obstetrics and Gynecology, Stavanger University Hospital, Stavanger, Norway.
Pétur B JúlíussonDepartment for Health Registry Research and Development, Norwegian Institute of Public Health, Bergen, Norway.
Karin KällénDepartment of Obstetrics and Gynecology, Institution of Clinical Sciences, Lund University, Lund, Sweden.ORCID 0000-0001-5765-2630
Mika GisslerDepartment of Knowledge Brokers, THL Finnish Institute of Health and Welfare, Helsinki, Finland.
Aura PyykönenHelsinki University, Helsinki, Finland.ORCID 0000-0001-9968-6660
Maija JakobssonDepartment of Obstetrics and Gynecology, HUS Hyvinkää Hospital, Helsinki University, Helsinki, Finland.
Lone KrebsDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-5433-4776
Hilde Marie EngjomDepartment for Health Promotion, Norwegian Institute of Public Health, Bergen, Norway.ORCID 0000-0003-1582-4283

Funding

NFOG fund 6506Norges Forskningsråd 320181Suomen Lääketieteen SäätiöThe Region of Southern Denmark and Region Zealand's shared fund for joint health research projects A767
6 · The paper itself

Abstract

introductionThe Coronavirus 2019 Disease (COVID-19) pandemic reached the Nordic countries in March 2020. Public health interventions to limit viral transmission varied across different countries both in timing and in magnitude. Interventions indicated by an Oxford Stringency Index ≥50 were implemented early (March 13-17, 2020) in Denmark, Finland, Norway and Iceland, and on March 26, 2020 in Sweden. The aim of the current study was to assess the incidence of COVID-19-related admissions of pregnant women in the Nordic countries in relation to the different national public health strategies during the first year of the pandemic. MATERIAL AND

methodsThis is a meta-analysis of population-based cohort studies in the five Nordic countries with national or regional surveillance in the Nordic Obstetric Surveillance System (NOSS) collaboration: national data from Denmark, Finland, Iceland and Norway, and regional data covering 31% of births in Sweden. The source population consisted of women giving birth in the included areas March 1-December 31, 2020. Pregnant women with a positive SARS-CoV-2 PCR test ≤14 days before hospital admission were included, and admissions were stratified as either COVID-19-related or non-COVID (other obstetric healthcare). Information about public health policies was retrieved retrospectively.

resultsIn total, 392 382 maternities were considered. Of these, 600 women were diagnosed with SARS-CoV-2 infection and 137 (22.8%) were admitted for COVID-19 symptoms. The pooled incidence of COVID-19 admissions per 1000 maternities was 0.5 (95% confidence interval [CI] 0.2 to 1.2, I

conclusionsThere was a clear variation in pregnant women's risk of COVID-19 admission across countries with similar healthcare systems but different public health interventions to limit viral transmission. The meta-analysis indicates that early suppression policies protected pregnant women from severe COVID-19 disease prior to the availability of individual protection with vaccines.

Indexed as

COVID-19Pregnancy Complications, InfectiousSARS-CoV-2AdultFemaleHumansIncidencePandemicsPopulation SurveillancePregnancyScandinavian and Nordic CountriesCOVID‐19incidenceNordic countriespregnancy outcomerisk factorSARS‐CoV‐2

Identifiers

PMID38382894
PMCPMC11103151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.